Shares of Nobilis Health Corp (NYSE:HLTH) have received a consensus broker rating score of 1.00 (Strong Buy) from the two brokers that cover the stock, Zacks Investment Research reports. Two analysts have rated the stock with a strong buy recommendation.
Brokerages have set a 1-year consensus target price of $5.25 for the company and are expecting that the company will post $0.08 EPS for the current quarter, according to Zacks. Zacks has also assigned Nobilis Health Corp an industry rank of 96 out of 265 based on the ratings given to its competitors.
HLTH has been the subject of several research reports. Zacks Investment Research lowered shares of Nobilis Health Corp from a “hold” rating to a “strong sell” rating in a report on Tuesday, July 12th. Canaccord Genuity initiated coverage on shares of Nobilis Health Corp in a report on Wednesday, July 13th. They issued a “buy” rating for the company.
Nobilis Health Corp (NYSE:HLTH) traded down 0.735% on Wednesday, hitting $3.375. 42,395 shares of the company were exchanged. Nobilis Health Corp has a 52 week low of $1.82 and a 52 week high of $4.66. The company has a 50 day moving average price of $3.47 and a 200-day moving average price of $3.15. The stock has a market capitalization of $259.14 million and a P/E ratio of 4.956.
Nobilis Health Corp (NYSE:HLTH) last issued its quarterly earnings data on Tuesday, August 2nd. The company reported $0.06 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.01 by $0.05. The company earned $61.90 million during the quarter, compared to the consensus estimate of $62.18 million. During the same quarter last year, the company posted ($0.02) earnings per share. The firm’s revenue for the quarter was up 26.6% compared to the same quarter last year. On average, equities analysts expect that Nobilis Health Corp will post $0.37 earnings per share for the current fiscal year.
Several hedge funds and other institutional investors have recently modified their holdings of the company. Summit Creek Advisors LLC raised its position in shares of Nobilis Health Corp by 19.4% in the third quarter. Summit Creek Advisors LLC now owns 1,861,316 shares of the company’s stock valued at $6,235,000 after buying an additional 302,340 shares during the last quarter. Royce & Associates LP raised its position in shares of Nobilis Health Corp by 28.7% in the second quarter. Royce & Associates LP now owns 1,590,800 shares of the company’s stock valued at $3,547,000 after buying an additional 355,100 shares during the last quarter. BlackRock Fund Advisors raised its position in shares of Nobilis Health Corp by 71.4% in the second quarter. BlackRock Fund Advisors now owns 1,424,287 shares of the company’s stock valued at $3,176,000 after buying an additional 593,140 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Nobilis Health Corp by 3.1% in the second quarter. Vanguard Group Inc. now owns 1,122,445 shares of the company’s stock valued at $2,503,000 after buying an additional 34,227 shares during the last quarter. Finally, Emerald Acquisition Ltd. acquired a new position in shares of Nobilis Health Corp during the second quarter valued at about $2,498,000.
About Nobilis Health Corp
Nobilis Health Corp. (Nobilis) owns and manages healthcare facilities in the States of Texas and Arizona, consisting primarily of ambulatory surgery centers (ASCs) and acute-care and surgical hospitals. The Company’s segments include Medical Services, Marketing Services and Corporate. The Medical Services segment owns and manages approximately nine healthcare facilities in Texas and Arizona; over four hospitals, and approximately five ambulatory surgery centers.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nobilis Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nobilis Health Corp and related companies with MarketBeat.com's FREE daily email newsletter.